We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$97.8M
2
AAPL icon
Apple
AAPL
+$7.77M
3
COST icon
Costco
COST
+$6.63M
4
FRO icon
Frontline
FRO
+$5.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.47M

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXO icon
1576
ALX Oncology
ALXO
$290M
– –
-48,204
Closed -$88K
AMH icon
1577
American Homes 4 Rent
AMH
$12.5B
– –
-32,122
Closed -$1.23M
AMG icon
1578
Affiliated Managers Group
AMG
$9.76B
– –
-3,882
Closed -$690K
ANAB icon
1579
AnaptysBio
ANAB
$1.68B
– –
-17,140
Closed -$574K
ANGO icon
1580
AngioDynamics
ANGO
$649M
– –
-91,769
Closed -$714K
ANNX icon
1581
Annexon
ANNX
$886M
– –
-34,581
Closed -$205K
APA icon
1582
APA Corp
APA
$13.2B
– –
-11,498
Closed -$281K
APPF icon
1583
AppFolio
APPF
$7.04B
– –
-4,420
Closed -$1.04M
APTV icon
1584
Aptiv
APTV
$10.3B
– –
-5,055
Closed -$364K
AQST icon
1585
Aquestive Therapeutics
AQST
$494M
– –
-137,151
Closed -$683K
ARES icon
1586
Ares Management
ARES
$30.9B
– –
-5,775
Closed -$900K
ARI
1587
Apollo Commercial Real Estate
ARI
$885M
– –
-45,953
Closed -$422K
ARLO icon
1588
Arlo Technologies
ARLO
$1.65B
– –
-108,053
Closed -$1.31M
ARMK icon
1589
Aramark
ARMK
$14.7B
– –
-35,227
Closed -$1.36M
ARQT icon
1590
Arcutis Biotherapeutics
ARQT
$3.18B
– –
-237,174
Closed -$2.21M
ASUR icon
1591
Asure Software
ASUR
$250M
– –
-44,616
Closed -$404K
ATI icon
1592
ATI
ATI
$31B
– –
-7,763
Closed -$519K
ATKR icon
1593
Atkore
ATKR
$3.16B
– –
-29,288
Closed -$2.48M
ATLO icon
1594
AMES National
ATLO
$277M
– –
-10,335
Closed -$188K
ATNI icon
1595
ATN International
ATNI
$492M
– –
-67,053
Closed -$2.17M
AUTL
1596
Autolus Therapeutics
AUTL
$562M
– –
-298,086
Closed -$1.08M
AVA icon
1597
Avista
AVA
$3.24B
– –
-15,745
Closed -$610K
AVPT icon
1598
AvePoint
AVPT
$2.71B
– –
-33,502
Closed -$394K
AVT icon
1599
Avnet
AVT
$7.92B
– –
-12,443
Closed -$676K
JBIO
1600
Jade Biosciences
JBIO
$1.34B
– –
-11,823
Closed -$865K
62 63
64
65 66

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.